Article
Differential expression of peroxiredoxins in prostate cancer: Consistent upregulation of PRDX3 and PRDX4
28 Oct 2010
Abstract excerpt
BACKGROUND: The peroxiredoxins (PRDXs) are emerging as regulators of antioxidant defense, apoptosis, and therapy resistance in cancer. Because their significance in prostate cancer (PCa) is unclear, we investigated their expression and clinical associations in PCa. METHODS: Transcript expression of PRDX1-6 in PCa was evaluated in cancer gene microarray datasets, whereas protein expression was evaluated by...